Skip to main content

Kybora settles its European headquarters in Basel

Basel_Urban_city_view_AdrianoBiondo
| News

Kybora settles its European headquarters in Basel

18.03.2021

The American consultancy Kybora, which operates within the life sciences industry, has established its European headquarters in Basel. Kybora GmbH will offer its services to European pharmaceutical companies from its location in Basel.

Basel_Urban_city_view_AdrianoBiondo

Kybora, a consulting firm based in the USA, is continuing its growth course from Basel, where it has founded Kybora GmbH and established its European headquarters according to a press release. Kybora aims to use this location to provide European life sciences companies with services in the areas of mergers and acquisitions, licensing, capital procurement, and strategic consulting.

Alan Vanderborght, Founder and CEO of Kybora, is quoted in the press release, saying: “Basel is the ideal location for our European headquarter.” He adds that the city has a “renowned pharma environment and a vibrant biotech industry” and is an ideal location right next to France and Germany, giving them “access to some of the brightest talents in these sectors”. Basel Area Business & Innovation, the location promotion and innovation support agency, helped Kybora during the relocation process.

Jean Chatellier will lead Kybora’s new European headquarters as Managing Director. He can rely on two decades of professional experience and pre-existing customers that will now be looked after from the Basel site. He further plans to arrange new, long-term partnerships with companies in Basel and across Europe.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.